- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,435GBP
- Report
- November 2025
- 337 Pages
Global
From €3998EUR$4,490USD£3,435GBP
- Report
- May 2026
- 185 Pages
Global
From €4007EUR$4,500USD£3,443GBP
- Report
- November 2025
- 180 Pages
Global
From €4007EUR$4,500USD£3,443GBP
- Report
- May 2026
- 185 Pages
Global
From €4007EUR$4,500USD£3,443GBP
- Report
- January 2026
- 180 Pages
Global
From €4007EUR$4,500USD£3,443GBP
- Report
- July 2026
- 200 Pages
Global
From €7114EUR$7,990USD£6,113GBP
- Report
- July 2026
- 164 Pages
Global
From €7114EUR$7,990USD£6,113GBP
- Report
- August 2026
- 120 Pages
Global
From €4229EUR$4,750USD£3,634GBP
- Report
- August 2026
- 117 Pages
Global
From €4229EUR$4,750USD£3,634GBP
- Report
- August 2026
- 131 Pages
Global
From €4229EUR$4,750USD£3,634GBP
- Report
- May 2026
- 150 Pages
Global
From €2403EUR$2,699USD£2,065GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2483EUR$2,789USD£2,134GBP
- Report
- May 2026
- 150 Pages
Global
From €2483EUR$2,789USD£2,134GBP
- Report
- May 2026
- 100 Pages
Global
From €2403EUR$2,699USD£2,065GBP
- Report
- March 2026
- 150 Pages
Global
From €2403EUR$2,699USD£2,065GBP
- Report
- July 2026
- 113 Pages
Global
From €4229EUR$4,750USD£3,634GBP
- Report
- January 2026
- 150 Pages
Global
From €3517EUR$3,950USD£3,022GBP

The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells.
Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more